Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 276 - 300 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
Actin (Muscle Specific)/HHF35 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MUSA IHC Disease useful as a marker for muscle and muscle-derived cells.This antibody recognizes actin
Actin (Smooth Muscle) (SMA) Alternative Name Smooth Muscle Actin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SMA IHC Disease smooth muscle tumorsSMA is a sensitive marker of myoepithelial
ADH-5 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ADH5 IHC Disease Breast CancerADH-5 simultaneously tests for 5 key markers (CK5/14, p63 and CK7/18) of breast disease in one simple
AFB Alternative Name Acid Fast Bacillus Methodology Special Stains Test Description Probes/Genes MC AFB Disease Acid Fast BacteriaMycobacterial IHC was well adopted with superior clinical performance to
Alcian Blue Methodology Special Stains Test Description Probes/Genes AB W/H SS Disease Barrett’s esophagus, as it will also stain goblet cells. mesothelioma, atherosclerosis and adenocarcinomas.Alcian
Alcian Blue/PAS Methodology Special Stains Test Description Probes/Genes AB W/H SS Disease Connective and epithelial tissue tumorsAlcian blue may be used in combination with the PAS staining procedure,
ALK D5F3 Lung Cancer Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ALK D5F3 IHC Disease Non-Small Cell Lung CancerScreening for anaplastic lymphoma kinase (ALK) rearrangements is
ALK-1 Lymphoma by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ALK1 IHC Disease Anaplastic Large Cell LymphomaALK-1 recognizes varying degrees of ALK expression in both the
Alpha Feto Protein Alternative Name Alpha-1-Fetoprotein (AFP) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes AFP IHC Disease Hepatocellular carcinoma, yolk sac tumor, testicular and
Amyloid A Methodology Immunohistochemistry (IHC) Test Description Probes/Genes Amyloid A IHC Disease AmyloidosisAmyloid A reacts with amyloid deposits in tissues. When accompanied by special stain Congo
Annexin A1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ANXA1 IHC Disease Hairy cell leukemiaAnnexin A1 is used to differentiate hairy cell leukemia from other B-cell lymphomas
Arginase-1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ARG1 IHC Disease Hepatocellular Carcinoma (HCC)Arginase-I is a key urea cycle metalloenzyme that has been used as an immunohistochemistry
B72.3 (TAG 72) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes B72.3 IHC Disease Most adenocarcinomasTumor-Associated Glycoprotein 72 (TAG-72) is an oncofetal mucin antigen expressed
BCA-225 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCA225 IHC Disease Breast CancerBCA-225 (Breast Cancer Antigen 225) is a 225 kD glycoprotein present in human breast carcinoma
BCL1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL1 IHC Disease MCL (mantle cell lymphoma), Hairy cell leukemia and plasmacytomaBCL1/Cyclin D1 is a nuclear protein detectable
BCL-1 (Cyclin D1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL1 IHC Disease MCL (mantle cell lymphoma), Hairy cell leukemia and plasmacytomaCyclin D1, a protein of 36 kD, is
BCL2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL2 IHC Disease Lymphoma (folicular, Diffuse Large Cell Lymphoma), bone cancer and stomach cancer.BCL-2 (B-cell lymphoma 2), encoded
BCL6 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL6 IHC Disease Lymphoma (mantle cell lymphoma, MALToma and anaplastic large cell lymphomas)BCL6 is a transcriptional suppressor
BerEP4 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BEREP4 IHC Disease Basal Cell Carcinoma (BCC)BerEP4 is a monoclonal antibody that can be used as a marker of BCC. It works by
Beta HCG Alternative Name Human Chorionic Gonadotropin Beta Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HCG IHC Disease Choriocarcinomas, germ cell tumorsHuman chorionic gonadotropin
Beta-Catenin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes Beta-Catenin IHC Disease Colorectal cancer resulting from familial adenomatous polyposis (FAP)The IHC Beta Catenin test
Bg8 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BG8 IHC Disease Adenocarcinoma, excludig mesotheliomaBG8 Lewisy, also known as Lewisy Blood Antigen or simply BG8, is a blood group
BOB1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BOB1 IHC Disease Hodgkin lymphomaBOB1 is present in all B-cells expressing Ig. BOB-1 antibody is a B-lymphocyte-specific transcriptional
BRAF by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BRAF IHC Disease Hairy Cell Leukemia, melanoma, thyroid cancer, lung cancer, NHL, langerhans cell histiocytosis (LCH)Serine/threonine-protein
CA-125 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CA125IHC Disease ovarian malignancies, cervical carcinoma, seminal vesicle carcinoma, anaplastic lymphoma, and endometrial and
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.